Constellium's (CSTM) Sell (D+) Rating Reaffirmed at Weiss Ratings

Key Points

• Constellium's stock received a "sell (d+)" rating from Weiss Ratings, indicating continued concerns about its performance, while the consensus rating among analysts is "Hold" with a target price of $18.25.
• The company's shares fell by 2.3% to $15.02 amid trading, with recent earnings results showing a miss on EPS estimates.
• Institutional investors hold a significant 92.59% stake in Constellium, with some firms significantly increasing their shareholdings recently.

Constellium (NYSE:CSTM - Get Free Report)'s stock had its "sell (d+)" rating reissued by research analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

A number of other research firms also recently commented on CSTM. Wells Fargo & Company started coverage on Constellium in a report on Wednesday. They issued an "equal weight" rating and a $16.00 price objective on the stock. Zacks Research downgraded Constellium from a "hold" rating to a "strong sell" rating in a report on Thursday, October 2nd. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $18.25.

Constellium Stock Down 2.3%

Shares of CSTM traded down $0.36 during trading hours on Wednesday, reaching $15.02. The company's stock had a trading volume of 1,356,725 shares, compared to its average volume of 1,108,442. The firm has a market cap of $2.10 billion, a price-to-earnings ratio of 79.06 and a beta of 1.71. Constellium has a 1-year low of $7.32 and a 1-year high of $16.49. The company has a quick ratio of 0.53, a current ratio of 1.23 and a debt-to-equity ratio of 2.47. The company has a 50 day moving average of $14.51 and a two-hundred day moving average of $12.74.

Constellium (NYSE:CSTM - Get Free Report) last issued its earnings results on Tuesday, July 29th. The industrial products company reported $0.25 earnings per share for the quarter, missing analysts' consensus estimates of $0.28 by ($0.03). The business had revenue of $2.10 billion during the quarter, compared to analyst estimates of $2.08 billion. Constellium had a net margin of 0.37% and a return on equity of 3.43%. As a group, research analysts predict that Constellium will post 1.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC lifted its stake in shares of Constellium by 2,485.6% in the first quarter. GAMMA Investing LLC now owns 2,689 shares of the industrial products company's stock worth $27,000 after acquiring an additional 2,585 shares during the period. Harvest Fund Management Co. Ltd acquired a new position in shares of Constellium in the first quarter worth approximately $38,000. US Bancorp DE lifted its stake in shares of Constellium by 1,034.7% in the first quarter. US Bancorp DE now owns 5,163 shares of the industrial products company's stock worth $52,000 after acquiring an additional 4,708 shares during the period. KBC Group NV acquired a new position in shares of Constellium in the second quarter worth approximately $56,000. Finally, Signaturefd LLC lifted its stake in shares of Constellium by 20.3% in the first quarter. Signaturefd LLC now owns 6,002 shares of the industrial products company's stock worth $61,000 after acquiring an additional 1,013 shares during the period. Institutional investors own 92.59% of the company's stock.

Constellium Company Profile

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.